Caribou Biosciences annual current ratio
2020
2021
2022
2023
2024
2025
Caribou Biosciences Current Ratio Growth & History (CRBU)
Caribou Biosciences's current ratio was 5.71 for fiscal 2025.
View full Caribou Biosciences company overviewCaribou Biosciences annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 5.71 | −1.44 | −20.16% |
| 2024 | 2024-12-31 | 7.16 | −4.82 | −40.22% |
| 2023 | 2023-12-31 | 11.97 | 2.72 | +29.40% |
| 2022 | 2022-12-31 | 9.25 | −5.89 | −38.91% |
| 2021 | 2021-12-31 | 15.15 | 13.18 | +671.98% |
| 2020 | 2020-12-31 | 1.96 | — | — |
Caribou Biosciences quarterly current ratio
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 6.49 | −0.18 | −2.66% |
| Q1 2026 | 2026-03-31 | 6.22 | −1.41 | −18.45% |
| Q4 2025 | 2025-12-31 | 5.71 | −1.44 | −20.16% |
| Q3 2025 | 2025-09-30 | 5.54 | −1.84 | −24.93% |
| Q2 2025 | 2025-06-30 | 6.66 | −2.09 | −23.87% |
| Q1 2025 | 2025-03-31 | 7.63 | −2.87 | −27.31% |
| Q4 2024 | 2024-12-31 | 7.16 | −4.82 | −40.22% |
| Q3 2024 | 2024-09-30 | 7.38 | −6.89 | −48.27% |
| Q2 2024 | 2024-06-30 | 8.75 | 0.94 | +12.06% |
| Q1 2024 | 2024-03-31 | 10.49 | 1.66 | +18.73% |
| Q4 2023 | 2023-12-31 | 11.97 | 2.72 | +29.40% |
| Q3 2023 | 2023-09-30 | 14.27 | 3.62 | +33.99% |
| Q2 2023 | 2023-06-30 | 7.81 | −4.42 | −36.13% |
| Q1 2023 | 2023-03-31 | 8.84 | −4.96 | −35.96% |
| Q4 2022 | 2022-12-31 | 9.25 | −5.89 | −38.91% |
| Q3 2022 | 2022-09-30 | 10.65 | −6.51 | −37.95% |
| Q2 2022 | 2022-06-30 | 12.23 | 6.73 | +122.49% |
| Q1 2022 | 2022-03-31 | 13.80 | — | — |
| Q4 2021 | 2021-12-31 | 15.15 | 13.18 | +671.98% |
| Q3 2021 | 2021-09-30 | 17.17 | — | — |
| Q2 2021 | 2021-06-30 | 5.50 | — | — |
| Q4 2020 | 2020-12-31 | 1.96 | — | — |
Caribou Biosciences current ratio trends
Over the last five fiscal years, Caribou Biosciences's current ratio increased from 1.96 to 5.71, a change of 3.75. The latest reported quarter, Q2 2026, shows 6.49.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Caribou Biosciences source filings ↗